AHMED NUMAAN: Open Payments
NPI 1437168358 · SHEBOYGAN, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 9 payments from 6 companies in 2025. Trend: 2023 $119 · 2024 $656 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $110 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| ABBVIE INC. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: LYBALVI, Auvelity, FANAPT, VRAYLAR, REXULTI, UZEDY.
Industry payments across WI — which companies pay providers there.
